Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Change in Cash (2016 - 2025)

Traws Pharma (TRAW) has disclosed Change in Cash for 14 consecutive years, with -$2.6 million as the latest value for Q4 2025.

  • For Q4 2025, Change in Cash fell 116.32% year-over-year to -$2.6 million; the TTM value through Dec 2025 reached -$17.5 million, down 3488.39%, while the annual FY2025 figure was -$17.5 million, 3488.39% down from the prior year.
  • Change in Cash hit -$2.6 million in Q4 2025 for Traws Pharma, up from -$6.7 million in the prior quarter.
  • Across five years, Change in Cash topped out at $29.0 million in Q1 2021 and bottomed at -$11.5 million in Q3 2024.
  • Average Change in Cash over 5 years is -$760250.0, with a median of -$4.3 million recorded in 2021.
  • Year-over-year, Change in Cash skyrocketed 617.13% in 2021 and then plummeted 675.81% in 2025.
  • Traws Pharma's Change in Cash stood at -$4.3 million in 2021, then increased by 10.49% to -$3.9 million in 2022, then decreased by 14.7% to -$4.4 million in 2023, then surged by 460.12% to $15.9 million in 2024, then plummeted by 116.32% to -$2.6 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$2.6 million, -$6.7 million, and -$2.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.